Previous close | 2.7800 |
Open | 2.9000 |
Bid | 2.7200 |
Ask | 2.9100 |
Strike | 40.00 |
Expiry date | 2025-06-20 |
Day's range | 2.6400 - 2.9000 |
Contract range | N/A |
Volume | |
Open interest | 670 |
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....
It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...